IL17A and breast carcinoma: Pathway analysis of the differentially expressed proteins in the co-cultured PBMCs vs. PBMC control cells revealed PPAR, IL-17, and PI3K-Akt as the most highly enriched signaling pathways, most likely involved in cancer progression including breast cancer.